GLP-1 receptor agonists e.g., semaglutide, liraglutide commonly cause gastrointestinal adverse effects such as nausea, vomiting, diarrhea, constipation, and abdominal discomfort, especially during dose escalation, less common risks include pancreatitis, gallbladder disease, and hypoglycemia mainly with insulin sulfonylureas
Impact of migraine on the tinnitus-specific health-related quality of life and psychiatric comorbidities in patients with tinnitus
For lipid peroxidation analysis, the cells were treated with 15 M RMC-4550, 10 nM trametinib, 10 nM RMC-7977, 10 M MRTX1133, or a combination of an SHP2 inhibitor and trametinib for 48 h
Franciscus A, Highleyman L